Seymour Tamara A's Form 4 filing
Zevra Therapeutics, Inc. (ZVRA) · filed Sep 16, 2025
- Accession no.
- 0001288232-25-000009
- Filed
- Sep 16, 2025
- Trade date
- Sep 12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $24.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seymour Tamara ACIK 0001288232 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Common Stock | PPurchaseAcquired | +3,175 | $7.79 | +$24,733.25 | 3,894 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.